What drugs does Y-MABS THERAPEUTICS INC make?

Y-MABS THERAPEUTICS INC has 1 FDA-approved drugs.

What therapeutic areas does Y-MABS THERAPEUTICS INC focus on?

Y-MABS THERAPEUTICS INC focuses primarily on Immunology and Oncology and 1 other therapeutic areas.

← Back

Data updated: Mar 29, 2026

Y-MABS THERAPEUTICS INC

ImmunologyOncologyDermatology

Biotech

Y-MABS THERAPEUTICS INC is a biotechnology company focused on Immunology, Oncology, Dermatology.

2020

Since

Drugs

Trials

Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues ProEarly access

Revenue Over Time ProEarly access

Competitive Matchups ProEarly access

Recent Activity

DANYELZA 2025-08-27

Labeling

SEC Filings ProEarly access

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Immunology 81%

0 drugs Phase 3: 5 Phase 2: 3

Oncology 13%

0 drugs Phase 1: 4

Dermatology 6%

0 drugs Phase 2: 1

Pipeline Forecast

Upcoming Trial Milestones ProEarly access

Patent Cliff ProEarly access

Competitors by Therapeutic Area

Pfizer big-pharma

Oncology, Dermatology, Immunology

Eli Lilly big-pharma

Oncology, Immunology, Dermatology

COSETTE other

Dermatology, Immunology, Oncology

Y-MABS THERAPEUTICS INC

Key Drugs

Top Drug Revenues ProEarly access

Revenue Over Time ProEarly access

Competitive Matchups ProEarly access

Recent Activity

Therapeutic Areas

Pipeline Forecast

Upcoming Trial Milestones ProEarly access

Patent Cliff ProEarly access

Competitors by Therapeutic Area

All Drugs (1)

Active (1)

Discontinued (0)

Company Info

Y-MABS THERAPEUTICS INC

Set Alert

Key Drugs

Top Drug Revenues ProEarly access

Revenue Over Time ProEarly access

Competitive Matchups ProEarly access

Recent Activity

Therapeutic Areas

Pipeline Forecast

Upcoming Trial Milestones ProEarly access

Patent Cliff ProEarly access

Competitors by Therapeutic Area

All Drugs (1)

Active (1)

Discontinued (0)

Company Info